Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07813858) titled 'Colchicine Effect on Amyotrophic Lateral Sclerosis Patients' on Sept. 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).

Primary Sponsor: Azienda Ospedaliero-Universitaria di Modena

Condition: Amyotrophic Lateral Sclerosis

Intervention: Drug: Colchicine 0.5 MG Oral Tablet

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: October 2026

Target Sample Size: 87

Countries of Recruitment: Italy

To know more, visit https://clinicaltrials.g...